MB Therapeutics wins French approval for 3D printed medicine cartridges

French startup MB Therapeutics has received ANSM pharmaceutical establishment authorization to manufacture semi-solid cartridges for 3D printing solid oral dosage forms. The company says it is the first site worldwide authorized to produce such cartridges; they will feed its printers in hospital pharmacies to print patient-specific doses.

• ANSM granted MB Therapeutics pharmaceutical manufacturer status in France
• Cartridges are patented airtight containers prefilled with API and excipients
• Printers target hospital pharmacies to print exact patient doses
• GMP operational compliance at the facility is still in progress